-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O2.6 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities II

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Leukemia, Adult, ALL, AML, Biological, Diseases, Lymphoma (any), bone marrow, Non-Biological, Bone Marrow Failure, Therapies, Combinations, Adverse Events, chemotherapy, MDS, Biological Processes, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, transplantation, microenvironment
Saturday, December 5, 2020: 12:00 PM-1:30 PM
Moderators:
Phuong T. Vo, MD, National Institutes of Health Clinical Center and Masumi Ueda Oshima, MD, University of Washington, Fred Hutchinson Cancer Research Center
Disclosures:
No relevant conflicts of interest to declare.
12:00 PM

Borje S. Andersson, M.D., Ph.D.1, Peter Thall2*, Benigno C. Valdez, PhD1, Junsheng Ma, MS3*, Julianne Chen4*, Sairah Ahmed, MD5, Amin M. Alousi, MD6, Qaiser Bashir, MD1, Stefan O. Ciurea, MD7, Alison Gulbis8*, Chitra Hosing, MD9, Roy B. Jones, MD, PhD1*, Jitesh Kawedia, BPharm10*, Partow Kebriaei, MD9, Steven M. Kornblau, MD11, Alan Myers, PharmD, PhD, RPh12*, Betul Oran, MD, MS13, Katayoun Rezvani, MD, PhD9, Nina Shah, MD14, Elizabeth J. Shpall, MD9, Simrit Parmar, M.D., MSCI15, Uday R. Popat, MD1, Yago Nieto, MD16 and Richard E. Champlin, MD9

1Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2M.D. Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
6Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
7The University of California, Irvine, Irvine, CA
8Pharmacy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
9Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
10The University of Texas MD Anderson Cancer Center, Houston
11Department of Stem Cell Transplantation, M.D. Anderson Cancer Center University of Texas, Houston, TX
12The University of Texas Health Sciences Center at Houston, Houston
13Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
14Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
15Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
16Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX

12:15 PM

Jacqueline S. Garcia, MD1, Haesook Kim2*, Corey Cutler, MD, MPH, FRCPC 3, Eric S. Winer, MD4, Richard M. Stone, MD4, Vincent T. Ho, MD1*, Rizwan Romee, MD2, John Koreth, MBBS, DPhil2, Mahasweta Gooptu, MD5, Sarah Nikiforow, MD, PhD1*, Roman M Shapiro, MD2, David P. Steensma, MD1, Marlise R. Luskin, MD2, Martha Wadleigh, MD4*, Fiona Loschi6*, Jeremy Ryan2*, Anthony Letai1*, R. Coleman Lindsley, MD, PhD1, Jennifer Brock2*, Robert J. Soiffer, MD7, Daniel J. DeAngelo, MD, PhD8 and Joseph H. Antin, MD5

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
5Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
6Dana-Farber Cancer Institute, Boston
7Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8Department of Medical Oncology, Dana-Farber Cancer Inst., Boston, MA

12:30 PM

Hongtao Liu, MD, PhD1, Bulent Aydogan, MD2*, Yasmin Hasan, MD2*, Amy Wang, MD, MPH1, Kamil Yenice, MD2*, Julien Partouche, MD2*, Wendy Stock, MD1, Richard A. Larson, MD1, Satyajit Kosuri, MD1*, James LaBelle, MD, PhD3*, Justin Kline, MD1, Peter A. Riedell, MD1, Andrew S. Artz, MD, MS4 and Michael R. Bishop, MD1

1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
2Dept. of Radiation & Cellular Oncology, University of Chicago, Chicago, IL
3Department of Pediatrics, Section of Hematology, University of Chicago, Chicago, IL
4City of Hope, Duarte, CA

12:45 PM

Anthony S. Stein, MD1, Monzr M. Al Malki, MD1, Dongyun Yang, PhD2*, Joycelynne Palmer, PhD2*, Ni-Chun Tsai, MS2*, Ibrahim Aldoss, M.D.1, Haris Ali, MD1, Ahmed Aribi, MD1*, Andrew S. Artz, MD, MS3, Len Farol, MD1,4*, Susanta Hui, PhD5*, Chatchada Karanes1, Samer Khaled, MD6, An Liu, MD7*, Guido Marcucci, MD8, Ryotaro Nakamura, M.D.1, Vinod A. Pullarkat, MD1, Eric Radany, MD7*, Joseph Rosenthal, MD, MS9, Amandeep Salhotra, MD1, James F Sanchez, PhD3*, Ricardo Spielberger, MD1,4*, David S Snyder, MD1, Stephen J. Forman, MD6 and Jeffrey Wong, MD7*

1Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
2Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
3City of Hope, Duarte, CA
4Bone Marrow Transplant Program, Southern California Kaiser Permanente, Los Angeles, CA
5Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, CA
6Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
7Department of Radiation Oncology, City of Hope, Duarte, CA
8Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Monrovia, CA
9Department of Pediatrics, City of Hope, Duarte, CA

1:00 PM

Boglarka Gyurkocza, MD1, Rajneesh Nath, MD2, Hannah Choe, MD3, Stuart Seropian, MD4, Patrick J. Stiff, MD5, Sunil Abhyankar, MD6, Edward Agura, MD7, Mark Litzow, MD8, Benjamin K. Tomlinson, MD9, George L. Chen, MD10, Parameswaran Hari, MBBS, MD11, Johnnie Orozco, MD12*, Zaid S. Al-Kadhimi, MD13*, Camille Abboud, MD14, Koen Van Besien, MD, PhD15, Mitchell Sabloff, MSc, MD, FRCPC16, Margarida Magalhaes Magalhaes-Silverman17, James M. Foran, MD18, Michael W. Schuster, MD19, Partow Kebriaei, MD20, Moshe Y. Levy, MD21, Hillard M Lazarus, MD22, Sergio A. Giralt, MD23, Qing Liang, PhD24*, Mark S. Berger, MD24, Vijay Reddy, MD, PhD24 and John M. Pagel, MD PhD25

1Memorial Sloan-Kettering Cancer Center, New York, NY
2Banner MD Anderson Cancer Center, Gilbert, AZ
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Hematology, Yale University School of Medicine, New Haven, CT
5Loyola University Chicago Stritch School of Medicine, Maywood, IL
6Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
7Baylor University Medical Center at Dallas, Dallas, TX
8Division of Hematology, Mayo Clinic, Rochester, MN
9Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
10Roswell Park Comprehensive Cancer Center, Buffalo, NY
11Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
12Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
13Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE
14Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
15Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
16Hematology, The Ottawa Hospital General Campus, Ottawa, ON, Canada
17Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
18Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
19Stony Brook University Hospital Cancer Center, Stony Brook, NY
20Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
21Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
22Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Cleveland Medical Center, Shaker Heights, OH
23Memorial Sloan Kettering Cancer Center, New York, NY
24Actinium Pharmaceuticals, Inc., New York, NY
25Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA

1:15 PM

Vinicius Campos de Molla, MD1,2, Vitor Heidrich1,3*, Julia Bruno1*, Franciele Knebel, PhD1*, Wanessa Miranda-Silva1*, Paula Asprino, PhD1*, Luciana Tucunduva, MD1*, Vanderson Rocha, MD, PhD3,4,5*, Yana Novis, MD1*, Anamaria Camargo, PhD1*, Eduardo Fregnani, PhD1* and Celso Arrais-Rodrigues, MD, PhD1,6

1Hospital Sírio Libanês, São Paulo, Brazil
2Universidade Federal de São Paulo, São Paulo, Brazil
3Universidade de São Paulo, São Paulo, Brazil
4Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
5Bone Marrow Transplant Department, Hospital Sírio Libanês, São Paulo, Brazil
6Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

*signifies non-member of ASH